newsfilter
← Latest News
GlobeNewswire·

GW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results and Operational Progress

- Total revenue increased 51 percent to $137.1 million – - Epidiolex for seizures associated with TSC launched in the U.S. -- Nabiximols Phase 3 program in MS spasticity now recruiting -- Conference...